Literature DB >> 23450693

Anti-citrullinated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients.

Lillian Barra1, Mathias Scinocca, Sheri Saunders, Rajesh Bhayana, Sherry Rohekar, Maud Racapé, Robert Coles, Ewa Cairns, David A Bell.   

Abstract

OBJECTIVE: First-degree relatives (FDRs) of rheumatoid arthritis (RA) patients sharing genetic and environmental risk factors for RA may represent a pre-RA state. Since anti-cyclic citrullinated protein/peptide antibodies (ACPAs) appear years before the onset of RA, the purpose of this study was to determine the prevalence of various ACPAs in FDRs of RA patients.
METHODS: We evaluated 88 RA patients, 50 unaffected FDRs, and 20 healthy control subjects. Six different types of ACPAs were determined by enzyme-linked immunosorbent assay. Joint and periodontal disease symptoms were self-reported. Patients and FDRs were HLA typed for the shared epitope (SE) and the RA-protective alleles HLA-DRB*1301/1302.
RESULTS: FDRs had a high prevalence of ACPAs (48%) as compared to controls (10%). Prevalence of the SE and smoking in FDRs was also high (62% and 49%, respectively). Of all of the ACPAs in the FDRs, 13 of 32 (41%) were of the IgA isotype. The most commonly expressed IgG ACPA targeted citrullinated vimentin, occurring in 20% of FDRs. The FDRs had an average of 1 type of ACPA, whereas the RA patients expressed a median of 5 different ACPAs. The only FDR to later develop RA expressed 4 different ACPAs. Joint and periodontal disease symptoms in the FDRs were significantly associated with smoking (OR 5.714 [95% confidence interval (95% CI) 1.151-28.3] and OR 12.25 [95% CI 2.544-58.99], respectively), but not with ACPAs.
CONCLUSION: The rate of ACPA positivity in unaffected FDRs of RA patients with a high prevalence of the SE and smoking was 48%, whereas ACPAs were rare in the healthy controls. ACPAs in the FDRs of RA patients was most commonly of the IgA isotype, but IgG ACPA targeting citrullinated vimentin was also frequently found.
Copyright © 2013 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23450693     DOI: 10.1002/art.37911

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  34 in total

1.  IL-22 regulates lymphoid chemokine production and assembly of tertiary lymphoid organs.

Authors:  Francesca Barone; Saba Nayar; Joana Campos; Thomas Cloake; David R Withers; Kai-Michael Toellner; Yang Zhang; Lynette Fouser; Benjamin Fisher; Simon Bowman; Javier Rangel-Moreno; Maria de la Luz Garcia-Hernandez; Troy D Randall; Davide Lucchesi; Michele Bombardieri; Costantino Pitzalis; Sanjiv A Luther; Christopher D Buckley
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-18       Impact factor: 11.205

Review 2.  Gene, environment, microbiome and mucosal immune tolerance in rheumatoid arthritis.

Authors:  Anca I Catrina; Kevin D Deane; Jose U Scher
Journal:  Rheumatology (Oxford)       Date:  2014-12-23       Impact factor: 7.580

3.  Anti-Citrullinated Protein Antibodies Are Associated With Neutrophil Extracellular Traps in the Sputum in Relatives of Rheumatoid Arthritis Patients.

Authors:  M Kristen Demoruelle; Kylie K Harrall; Linh Ho; Monica M Purmalek; Nickie L Seto; Heather M Rothfuss; Michael H Weisman; Joshua J Solomon; Aryeh Fischer; Yuko Okamoto; Lindsay B Kelmenson; Mark C Parish; Marie Feser; Chelsie Fleischer; Courtney Anderson; Michael Mahler; Jill M Norris; Mariana J Kaplan; Brian D Cherrington; V Michael Holers; Kevin D Deane
Journal:  Arthritis Rheumatol       Date:  2017-05-02       Impact factor: 10.995

4.  Timing of Elevations of Autoantibody Isotypes Prior to Diagnosis of Rheumatoid Arthritis.

Authors:  Lindsay B Kelmenson; Brandie D Wagner; Bryan K McNair; Ashley Frazer-Abel; M Kristen Demoruelle; Dylan T Bergstedt; Marie L Feser; Laura K Moss; Mark C Parish; Elizabeth A Mewshaw; Ted R Mikuls; Jess D Edison; V Michael Holers; Kevin D Deane
Journal:  Arthritis Rheumatol       Date:  2019-12-26       Impact factor: 10.995

Review 5.  Individuals at risk of seropositive rheumatoid arthritis: the evolving story.

Authors:  S Rantapää Dahlqvist; F Andrade
Journal:  J Intern Med       Date:  2019-10-21       Impact factor: 8.989

Review 6.  Preclinical Rheumatoid Arthritis and Rheumatoid Arthritis Prevention.

Authors:  Kevin D Deane
Journal:  Curr Rheumatol Rep       Date:  2018-06-26       Impact factor: 4.592

Review 7.  Genetic and environmental risk factors for rheumatoid arthritis.

Authors:  Kevin D Deane; M Kristen Demoruelle; Lindsay B Kelmenson; Kristine A Kuhn; Jill M Norris; V Michael Holers
Journal:  Best Pract Res Clin Rheumatol       Date:  2017-09-18       Impact factor: 4.098

Review 8.  The Complex Role of the Lung in the Pathogenesis and Clinical Outcomes of Rheumatoid Arthritis.

Authors:  Lindsay B Kelmenson; M Kristen Demoruelle; Kevin D Deane
Journal:  Curr Rheumatol Rep       Date:  2016-11       Impact factor: 4.592

Review 9.  Autoimmunity to citrullinated proteins and the initiation of rheumatoid arthritis.

Authors:  V Michael Holers
Journal:  Curr Opin Immunol       Date:  2013-11-08       Impact factor: 7.486

10.  Performance of anti-cyclic citrullinated Peptide assays differs in subjects at increased risk of rheumatoid arthritis and subjects with established disease.

Authors:  M Kristen Demoruelle; Mark C Parish; Lezlie A Derber; Jason R Kolfenbach; Jan M Hughes-Austin; Michael H Weisman; William Gilliland; Jess D Edison; Jane H Buckner; Ted R Mikuls; James R O'Dell; Richard M Keating; Peter K Gregersen; Jill M Norris; V Michael Holers; Kevin D Deane
Journal:  Arthritis Rheum       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.